Related Experiment Videos
Molecular pathways in the formation of gliomas
A von Deimling1, D N Louis, O D Wiestler
1Department of Neuropathology, University of Bonn Medical Center, Germany.
Abstract:
The past few years have seen remarkable progress in understanding the molecular genetic basis of glioma formation. Affected oncogenes and tumor suppressor genes have been identified and putative tumor suppressor loci have been mapped. These studies have illustrated distinct molecular pathways for different glial neoplasms. We summarize the findings of an ongoing study initiated to characterize human gliomas on a molecular basis. The data are compiled from 150 astrocytic, oligodendroglial, and mixed gliomas that were assessed for genomic alterations characteristic of these neoplasms, i.e., loss of portions of chromosomes 1p, 9p, 10, 17p, 17q, and 19q, mutations of the p53 tumor suppressor gene, and amplification of the EGF receptor (EGFR) gene. Our findings support the hypothesis that distinct genetic pathways result in the formation of astrocytic and oligodendroglial neoplasms of different malignancy grades, and that glioblastoma multiforme may be subdivided into genetically distinct subsets. Such findings may not only lead to a better understanding of neoplastic transformation in glial cells, but may also have a major impact on clinical neuro-oncology.
Insights
This study reveals distinct genetic pathways in glioma formation, differentiating astrocytic and oligodendroglial tumors. Findings may impact neuro-oncology by classifying glioblastoma into genetically unique subsets.
Area of Science:
- Neuro-oncology
- Molecular genetics
- Cancer research
Background:
- Glioma formation involves complex molecular genetic alterations.
- Distinct molecular pathways characterize different glial neoplasms.
- Understanding these pathways is crucial for diagnosis and treatment.
Purpose of the Study:
- To characterize human gliomas on a molecular genetic basis.
- To identify genomic alterations in astrocytic, oligodendroglial, and mixed gliomas.
- To investigate distinct genetic pathways in glioma development.
Main Methods:
- Analysis of 150 gliomas (astrocytic, oligodendroglial, mixed).
- Assessment of genomic alterations: chromosomal losses (1p, 9p, 10, 17p, 17q, 19q).
- Evaluation of p53 gene mutations and Epidermal Growth Factor Receptor (EGFR) gene amplification.
Main Results:
- Distinct genetic pathways identified for astrocytic and oligodendroglial neoplasms.
- Evidence supports different pathways for varying malignancy grades.
- Glioblastoma multiforme may comprise genetically distinct subsets.
Conclusions:
- Molecular genetic characterization aids in understanding glioma formation.
- Findings support distinct genetic pathways for different glioma types and grades.
- Potential for improved clinical neuro-oncology through genetic subtyping.